ArticleIn silico pharmacology2025

In silico evaluation of berberine and silymarin against metabolic targets: a rationale for OMICS technology-based co-formulation.

Augustine Amalraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.